Theiner S, Lacková M, Russo R, Dvořák Z, Lipový B, Knoz M
Acta Chir Plast. 2025;67(1):42-54. doi: 10.48095/ccachp202542.
Lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) are both accepted microsurgical treatment options for lymphedema. This article summarises and analyses recent data on outcomes associated with LVA and VLNT for lymphedema treatment at varying degrees of severity.
Literature research was conducted in the PubMed and Embase Ovid database to extract articles published through March 2024. The included studies report data on objective and subjective improvement in lymphedema after physiological surgical procedures as LVA and VLNT. Extracted data comprised number of patients, affected limbs, staging of the disease, duration of the follow up period, objective and subjective improvement and percentage of discontinuation of compression garments.
A total of 23 articles were included in this article, representing 1,944 patients suffering from either primary or secondary lymphedema. The lymphedema stages were classified by classification of International Society of Lymphedema (ISL stage) or Campisi stage and range from stage I to III, as well as prophylactic indication for surgery. The follow-up duration ranged from 3 months to 8 years. Objective improvement was achieved in 82.76-100% and measured in circumferential reduction rate and reduction of cellulitis episodes. In 80-100% of the patient's subjective improvement was seen, which was measured in quality of life and personal feedback. The percentage of patients able to discontinue the use of compression garments ranges from 0 to 100%, while others were able to reduce the total time of wearing.
LVA and VLNT are both safe and effective techniques for the surgical treatment of lymphedema in several stages. LVA should be preferred if the lymph vessels preserved its patency, otherwise VLNT might be the therapy of choice. Combinations of various procedures with an appropriate postoperative treatment plan might lead to improved patient outcomes.
淋巴静脉吻合术(LVA)和带血管蒂淋巴结转移术(VLNT)都是公认的治疗淋巴水肿的显微外科手术选择。本文总结并分析了近期关于不同严重程度淋巴水肿的LVA和VLNT治疗效果的数据。
在PubMed和Embase Ovid数据库中进行文献研究,以提取截至2024年3月发表的文章。纳入的研究报告了LVA和VLNT等生理性外科手术后淋巴水肿客观和主观改善的数据。提取的数据包括患者数量、受累肢体、疾病分期、随访期时长、客观和主观改善情况以及停用压力衣的百分比。
本文共纳入23篇文章,代表1944例原发性或继发性淋巴水肿患者。淋巴水肿分期采用国际淋巴水肿学会(ISL分期)或坎皮西分期,范围从I期到III期,以及手术的预防性指征。随访期时长从3个月到8年不等。客观改善率为82.76%至100%,通过周径缩小率和蜂窝织炎发作次数减少来衡量。80%至100%的患者有主观改善表现,通过生活质量和个人反馈来衡量。能够停用压力衣的患者百分比从0到100%不等,其他患者则能够减少穿戴压力衣的总时长。
LVA和VLNT都是治疗多个阶段淋巴水肿的安全有效技术。如果淋巴管保持通畅,应首选LVA,否则VLNT可能是首选治疗方法。各种手术与适当的术后治疗方案相结合可能会改善患者的治疗效果。